DAVID KAMINSKI: Open Payments
NPI 1164419123 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 12 payments from 5 companies in 2025. Trend: 2023 $147 · 2024 $109 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| Ferring Pharmaceuticals Inc. | 3 | $79 |
| Janssen Biotech, Inc. | 3 | $72 |
| Heron Therapeutics, Inc. | 1 | $29 |
| Solventum Corporation | 1 | $14 |
Products named: DUPIXENT, EUFLEXXA, TREMFYA, ZYNRELEF, PREVENA.
Industry payments across MI — which companies pay providers there.
